Loading organizations...
§ Venture Capital · Beijing, Beijing, China
Venture capital firm investing in healthcare and life sciences companies, leveraging global innovations and China's advantages.
Key people at Hyfinity Investments.
Hyfinity Investments was founded in 2016 by Dr. Sylvia Xin He (Managing Partner and Founder).
Hyfinity Investments, a venture capital firm focused on healthcare, was founded by Managing Partner Dr. Xin He. The firm strategically leverages global innovations alongside China's significant market advantages, including substantial unmet medical needs and extensive clinical resources, to cultivate industry leaders. Its leadership team comprises senior partners from top-tier Chinese investment institutions, bringing deep expertise in healthcare investing, local operations, and overseas licensing. Hyfinity demonstrated its investment activity by leading Elpiscience Biopharma's Series B financing of USD 100 million in December 2019. The firm also led Carcell Biopharma's oversubscribed financing round in 2021 and participated in Oculis' oversubscribed US$57 million Series C. Its business model centers on venture capital investments in healthcare companies, generating returns through portfolio company growth, exits, and licensing deals.
Key people at Hyfinity Investments.
Hyfinity Investments was founded in 2016 by Dr. Sylvia Xin He (Managing Partner and Founder).
Hyfinity Investments has 1 tracked investment across 1 company. The latest tracked deal is $19.2M Pre-Series A in Cargene in December 2021.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Dec 15, 2021 | Cargene | $19.2M Pre-Series A | — | — |